Great Lakes Advisors LLC Has $15.38 Million Holdings in Encompass Health Corporation $EHC

Great Lakes Advisors LLC decreased its position in Encompass Health Corporation (NYSE:EHC) by 40.3% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 121,085 shares of the company’s stock after selling 81,572 shares during the period. Great Lakes Advisors LLC’s holdings in Encompass Health were worth $15,380,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in EHC. Alliancebernstein L.P. lifted its holdings in shares of Encompass Health by 6.8% in the second quarter. Alliancebernstein L.P. now owns 2,039,314 shares of the company’s stock valued at $250,081,000 after purchasing an additional 129,276 shares in the last quarter. Geode Capital Management LLC raised its position in Encompass Health by 0.5% during the second quarter. Geode Capital Management LLC now owns 1,773,547 shares of the company’s stock valued at $217,526,000 after buying an additional 8,765 shares during the period. Raymond James Financial Inc. lifted its stake in Encompass Health by 31.5% in the 2nd quarter. Raymond James Financial Inc. now owns 1,143,642 shares of the company’s stock worth $140,245,000 after acquiring an additional 274,142 shares in the last quarter. Norges Bank acquired a new stake in Encompass Health during the 2nd quarter worth about $139,536,000. Finally, Franklin Resources Inc. grew its stake in Encompass Health by 25.9% during the 2nd quarter. Franklin Resources Inc. now owns 1,031,448 shares of the company’s stock valued at $126,486,000 after acquiring an additional 212,435 shares in the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Stock Down 1.3%

Encompass Health stock opened at $94.44 on Friday. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 1-year low of $92.53 and a 1-year high of $127.99. The firm’s fifty day simple moving average is $106.45 and its 200-day simple moving average is $114.99. The company has a market capitalization of $9.50 billion, a P/E ratio of 17.85, a P/E/G ratio of 1.54 and a beta of 0.74.

Encompass Health (NYSE:EHC) last posted its earnings results on Wednesday, October 29th. The company reported $1.23 EPS for the quarter, topping the consensus estimate of $1.19 by $0.04. Encompass Health had a net margin of 9.33% and a return on equity of 17.84%. The firm had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.48 billion. During the same period in the prior year, the business posted $1.03 earnings per share. The business’s quarterly revenue was up 9.4% on a year-over-year basis. Sell-side analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts recently commented on EHC shares. Barclays raised their price target on shares of Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a report on Thursday, October 30th. Raymond James Financial raised shares of Encompass Health to a “strong-buy” rating in a research note on Friday, October 31st. Zacks Research downgraded shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Weiss Ratings reiterated a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. Finally, UBS Group boosted their target price on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Thursday, October 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $142.86.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.